NCT07205510 Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)
| NCT ID | NCT07205510 |
| Status | Recruiting |
| Phase | — |
| Sponsor | RenJi Hospital |
| Condition | Sarcopenia |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2020-12-01 |
| Primary Completion | 2040-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2020-12-01 with a primary completion date of 2040-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to establish an ambispective cohort platform centered on the pathological axis of "sarcopenia-metabolic disorders-aging progression", integrating multimodal data including demographic characteristics, lifestyle factors, clinical phenotypes, laboratory tests, medical imaging, and biospecimens. Namely 'Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)'.
Eligibility Criteria
Inclusion Criteria: Adults aged 18 and over Exclusion Criteria: 1. Does not cooperate in signing the informed consent form; 2. Does not possess legal capacity; 3. In a state of loss of consciousness; 4. Suffering from severe mental illness, unable to communicate normally; 5. The researcher believes that the subject has a disease that affects the assessment of results and is unsuitable for inclusion.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07205510 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sarcopenia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07205510 currently recruiting?
Yes, NCT07205510 is actively recruiting participants. Contact the research team at 11084@renji.com for enrollment information.
Where is the NCT07205510 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT07205510 clinical trial?
NCT07205510 is sponsored by RenJi Hospital. The trial plans to enroll 10,000 participants.